{"id":"01a1df67-0382-7f53-b132-ad0f2d5ad37e","name":"Pharmaceutical MRP revisions and estimated savings reporting","situation_type":"market_shift","status":"active","start_date":"2026-11-04","end_date":null,"confidence":0.62,"member_count":3,"summary":"Three linked items describe revised maximum retail prices (MRPs) announced by pharmaceutical companies for a set of drugs, together with estimated savings figures. One announcement covers 70 companies and 120 drugs; a report attaches an estimated saving of ₹3,357.49 crore to that same 70-company/120-drug figure; a third item reports 85 companies and 121 drugs with estimated savings of ₹3,541 crore. The cluster reflects price-revision reporting in the pharmaceutical market rather than a single named event.","place":null,"places":[],"intensity":null,"unknowns":[],"known_at":"2026-11-15T13:30:32.695646Z","actors":[],"members":[{"kind":"event","id":"01a1df49-a4b8-7dfe-820e-502d16dd2973","title":"70 companies announced revised MRPs for 120 drugs","type_code":"announcement","status":"completed","date":"2026-11-04","role":"part_of"},{"kind":"event","id":"01a1df4d-592e-73bc-9201-79e057109ddc","title":"Estimated savings of ₹3,357.49 crore with 70 companies reporting revised MRPs for 120 drugs","type_code":"report","status":"completed","date":"2026-11-04","role":"part_of"},{"kind":"event","id":"01a1df4e-8ebf-7a08-8d21-791a3b42e736","title":"85 companies report revised MRPs for 121 drugs, estimated savings ₹3,541 crore","type_code":"price_revision_reporting","status":"completed","date":null,"role":"part_of"}],"evidence":null}